Complete Filing Data
IMA Tech reported Net Income Loss of -$55.1 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean IMA Tech did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue * | $55.4K | $10.8K | |
| Net Income Loss | -$55.1K | -$27.8K | -$31.00 |
| Operating Income Loss | -$55.1K | -$27.8K | -$31.00 |
| General And Administrative Expense | $53.5K | $23.2K | $31.00 |
| Operating Expenses | $110.4K | $38.6K | $31.00 |
| Deferred Revenue | $4.7K | ||
| Net Income Loss Available To Common Stockholders Basic | -$27.8K | -$31.00 | |
| Deferred Revenue Current | |||
| Amortization Of Intangible Assets | $15.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $65.7K | $4.4K | $27.3K | $10.0K | $4.7K | $10.8K | ||||
| Net Income Loss | -$1.9K | -$20.9K | $1.3K | -$12.9K | -$17.1K | $2.3K | -$8.8K | -$9.7K | ||
| Operating Income Loss | -$1.9K | -$20.9K | $1.3K | -$12.9K | -$17.1K | $2.3K | -$8.8K | $9.7K | ||
| General And Administrative Expense | $53.4K | $11.0K | $11.7K | $8.6K | $7.6K | $3.0K | $7.5K | $9.0K | ||
| Operating Expenses | $67.7K | $25.3K | $25.9K | $22.9K | $21.8K | $8.5K | $8.8K | $9.7K | ||
| Deferred Revenue | $5.3K | $15.4K | $4.4K | $15.2K | $4.5K | |||||
| Net Income Loss Available To Common Stockholders Basic | ||||||||||
| Deferred Revenue Current | $4.7K | |||||||||
| Amortization Of Intangible Assets |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity * | $4.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.0K | ||
| Retained Earnings Accumulated Deficit | -$27.9K | -$31.00 | |
| Other Assets | $269.2K | $13.4K | |
| Liabilities Current | $296.1K | $25.4K | |
| Liabilities And Stockholders Equity | $276.9K | $29.4K | |
| Liabilities | $296.1K | $25.4K | |
| Common Stock Value | $4.2K | $4.0K | |
| Cash And Cash Equivalents At Carrying Value | $7.7K | $16.0K | |
| Assets Current | $7.7K | $16.0K | |
| Assets | $276.9K | $29.4K | |
| Accounts Payable Current | $96.5K | $13.4K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.2K | -$8.3K | $16.0K |
| Intangible Assets Net Excluding Goodwill | $269.2K | $13.4K | |
| Other Liabilities Current | $194.9K | ||
| Repayment Of Notes Receivable From Related Parties | $928.00 | ||
| Other Assets Noncurrent | |||
| Loans Payable Current | $194.9K | $12.0K | |
| Accounts And Notes Receivable Net | |||
| Other Assets Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$68.4K | -$66.5K | -$45.6K | -$19.2K | -$20.5K | -$35.3K | -$19.2K | -$12.2K | -$14.6K | -$5.8K | $4.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $598.00 | $11.9K | $4.5K | $530.00 | $10.1K | $530.00 | $7.7K | $11.4K | $543.00 | $465.00 | |
| Retained Earnings Accumulated Deficit | -$105.7K | -$103.8K | -$82.9K | -$56.5K | -$57.8K | -$45.0K | -$16.2K | ||||
| Other Assets | $183.8K | $198.0K | $212.3K | $226.5K | $240.7K | $255.0K | $153.2K | ||||
| Liabilities Current | $279.0K | $278.9K | $267.3K | $253.6K | $275.4K | $290.8K | $176.8K | ||||
| Liabilities And Stockholders Equity | $210.5K | $212.4K | $221.7K | $234.4K | $254.8K | $255.5K | $164.6K | ||||
| Liabilities | $279.0K | $278.9K | $267.3K | $253.6K | $275.4K | $290.8K | $176.8K | ||||
| Common Stock Value | $2.6K | $5.1K | $5.1K | $5.1K | $5.1K | $4.2K | $4.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $598.00 | $11.9K | $4.5K | $530.00 | $10.1K | $530.00 | $11.4K | ||||
| Assets Current | $26.7K | $14.4K | $9.4K | $7.9K | $10.1K | $530.00 | $11.4K | ||||
| Assets | $210.5K | $212.4K | $221.7K | $234.4K | $254.8K | $255.5K | $164.6K | ||||
| Accounts Payable Current | $198.00 | $10.8K | $10.1K | $16.6K | $63.0K | $89.3K | $72.2K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $7.4K | -$7.2K | -$15.5K | ||||||||
| Intangible Assets Net Excluding Goodwill | $183.8K | $198.0K | $212.3K | $226.5K | $255.0K | $153.2K | |||||
| Other Liabilities Current | $273.5K | $252.7K | $252.8K | $237.0K | $197.2K | $196.9K | |||||
| Repayment Of Notes Receivable From Related Parties | $100.00 | ||||||||||
| Other Assets Noncurrent | $240.7K | $269.2K | |||||||||
| Loans Payable Current | |||||||||||
| Accounts And Notes Receivable Net | $104.6K | $12.0K | |||||||||
| Other Assets Current | $4.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$89.7K | $75.4K | $13.4K |
| Net Cash Provided By Used In Financing Activities | $86.5K | $187.6K | $16.0K |
| Increase Decrease In Accounts Payable | -$86.4K | $83.1K | $13.4K |
| Proceeds From Related Party Debt | $58.8K | $182.9K | $12.0K |
| Increase Decrease In Deferred Revenue | -$300.00 | $4.7K | |
| Proceeds From Issuance Or Sale Of Equity | $28.6K | $4.6K | $4.0K |
| Net Cash Provided By Used In Investing Activities | -$271.2K | $13.4K | |
| Increase Decrease In Prepaid Expense | -$4.9K | ||
| Depreciation Depletion And Amortization | $56.9K | $15.5K | |
| Proceeds From Issuance Of Common Stock | |||
| Payments To Acquire Other Productive Assets | $271.2K | $13.4K | |
| Payments For Proceeds From Other Investing Activities | $271.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q4 2024 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $7.5K | -$10.3K | -$22.4K | |
| Net Cash Provided By Used In Financing Activities | -$100.00 | $3.1K | $6.9K | |
| Increase Decrease In Accounts Payable | $703.00 | -$7.2K | -$13.4K | |
| Proceeds From Related Party Debt | $2.0K | $6.9K | ||
| Increase Decrease In Deferred Revenue | $11.0K | -$200.00 | ||
| Proceeds From Issuance Or Sale Of Equity | $1.1K | |||
| Net Cash Provided By Used In Investing Activities | ||||
| Increase Decrease In Prepaid Expense | $2.5K | |||
| Depreciation Depletion And Amortization | $14.2K | $14.2K | ||
| Proceeds From Issuance Of Common Stock | $27.6K | $1.1K | ||
| Payments To Acquire Other Productive Assets | ||||
| Payments For Proceeds From Other Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Shares Outstanding | 4.0M | ||
| Weighted Average Number Of Shares Outstanding Basic | 4.8M | 4.0M | 4.0M |
| Earnings Per Share Basic | $-0.01 | $-0.01 | $0.00 |
| Common Stock Shares Outstanding | 4.2M | 4.0M | |
| Shares Issued | |||
| Common Stock Shares Authorized | 75.0M | 75.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Common Stock Shares Issued |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding | 2.6M | 5.1M | 5.1M | 5.1M | 5.1M | 4.2M | 4.2M | 4.0M | |||
| Weighted Average Number Of Shares Outstanding Basic | 2.7M | 5.1M | 5.1M | 4.7M | 4.1M | 4.0M | 4.0M | 4.0M | |||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 2.6M | 5.1M | 5.1M | 5.1M | 5.1M | 4.2M | 4.0M | ||||
| Shares Issued | 5.1M | 4.2M | 4.2M | 4.0M | 4.0M | 4.0M | 4.0M | ||||
| Common Stock Shares Authorized | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 4.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Issued | 5.1M | 5.1M | 5.1M | 5.1M | 4.2M | 4.2M | 4.0M | 4.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Depreciation And Amortization | $56.9K | $15.5K | |
| Additional Paid In Capital | $4.5K | ||
| Stock Issued During Period Shares New Issues | 954.9K | 155.0K | |
| Prepaid Expense Current | |||
| Amortization Of Acquisition Costs | |||
| Stock Issued During Period Value New Issues | $4.6K | $4.0K | |
| Stock Issued During Period Value Other | $28.6K | $4.6K | |
| Stockcancelled During Period | |||
| Stock Issued During Period Shares Period Increase Decrease | |||
| Professional Fees | $22.6K | ||
| Adjustment For Amortization | $15.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $14.2K | $14.2K | $14.2K | $14.2K | $14.2K | $5.4K | $1.3K | $670.00 | |
| Additional Paid In Capital | $34.7K | $32.2K | $32.2K | $32.2K | $32.2K | $5.5K | |||
| Stock Issued During Period Shares New Issues | 919.4K | 35.5K | |||||||
| Prepaid Expense Current | $26.1K | $2.5K | $4.9K | $7.4K | $4.0K | ||||
| Amortization Of Acquisition Costs | $14.2K | $670.00 | |||||||
| Stock Issued During Period Value New Issues | $27.6K | $1.1K | |||||||
| Stock Issued During Period Value Other | |||||||||
| Stockcancelled During Period | -$2.5M | ||||||||
| Stock Issued During Period Shares Period Increase Decrease | 35.5K | ||||||||
| Professional Fees | |||||||||
| Adjustment For Amortization |
Most recent annual filing with the SEC: July 22, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.